Retrospective reimbursement prices for May and June 2026
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined May and June 2026 reimbursement prices for the following products to reflect an increase in their NHS list prices.
To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to grant retrospective price adjustments for the following products prescribed by brand or generically. These interventions by our Dispensing and Supply Team have prevented community pharmacies from losing an estimated £80k to medicine price rises.
June 2026 price adjustments
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined reimbursement price | Drug Tariff Category |
| Goserelin 3.6mg implant pre-filled syringes | Zoladex 3.6mg implant SafeSystem pre-filled syringes (AstraZeneca UK Ltd) | 1 pre-filled disposable injection | £70.00 | £94.50 | Part VIIIA Category C |
| Generic ProSource Plus liquid 30ml sachets gluten free | ProSource Plus liquid 30ml sachets both unflavoured and flavoured (orange crème, neutral, citrus berry) (Nutrinovo Ltd) | 100 sachet | £204.89 | £213.18 | Non-Dug Tariff |
| Generic ProSource TF liquid 45ml sachets gluten free | ProSource TF liquid 45ml sachets (Nutrinovo Ltd) | 100 sachet | £164.21 | £170.86 | Non-Dug Tariff |
| Generic ProSource liquid 30ml sachets gluten free | ProSource liquid 30ml sachets both unflavoured and flavoured (orange crème, neutral, citrus berry) (Nutrinovo Ltd) | 100 sachet | £152.84 | £159.03 | Non-Dug Tariff |
| Generic ProSource Plus liquid 30ml sachets gluten free | ProSource Plus liquid 30ml sachets both unflavoured and flavoured (orange crème, neutral, citrus berry) (Nutrinovo Ltd) | 50 sachet | £102.45 | £106.59 | Non-Dug Tariff |
| Generic HyFiber liquid 30ml sachets gluten free | HyFiber liquid 30ml sachets (Nutrinovo Ltd) | 100 sachet | £116.55 | £119.93 | Non-Dug Tariff |
May 2026 price adjustments
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined reimbursement price | Drug Tariff Category |
| Generic TYR sphere20 oral powder 35g sachets | TYR sphere20 oral powder 35g sachets red berry (Vitaflo International Ltd) | 30 sachet | £742.01 | £772.80 | Non-Drug Tariff |
| Generic TYR sphere20 oral powder 35g sachets | TYR sphere20 oral powder 35g sachets vanilla (Vitaflo International Ltd) | 30 sachet | £742.01 | £772.80 | Non-Drug Tariff |
| Generic PKU sphere15 oral powder 27g sachets | PKU sphere15 oral powder 27g sachets chocolate (Vitaflo International Ltd) | 30 sachet | £362.86 | £377.91 | Non-Drug Tariff |
| Generic PKU sphere15 oral powder 27g sachets | PKU sphere15 oral powder 27g sachets vanilla (Vitaflo International Ltd) | 30 sachet | £362.86 | £377.91 | Non-Drug Tariff |
| Generic PKU sphere15 oral powder 27g sachets | PKU sphere15 oral powder 27g sachets red berry (Vitaflo International Ltd) | 30 sachet | £362.86 | £377.91 | Non-Drug Tariff |
| Generic Thick & Easy powder | Thick & Easy Original powder (Fresenius Kabi Ltd) | 4540 gram | £131.73 | £136.87 | Non-Drug Tariff |
| Generic Thick & Easy powder | Thick & Easy Original powder (Fresenius Kabi Ltd) | 225 gram | £6.27 | £6.51 | Non-Drug Tariff |
| Salbutamol 100micrograms/dose dry powder inhaler | Easyhaler Salbutamol sulfate 100micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) | 200 dose | £3.31 | £4.05 | Category C |
| Salbutamol 200micrograms/dose dry powder inhaler | Easyhaler Salbutamol sulfate 200micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) | 200 dose | £6.63 | £8.12 | Category C |
Under the current price change mechanism, pharmacy owners would have to wait one (or in some cases two months) before any NHS list prices changes are applied to reimbursement of branded products. The delays in reimbursement prices catching up with any NHS list price increases can lead to dispensing at a loss, as pharmacies will be reimbursed based on the previous NHS list price until the price change is adjusted in line with the price change timetable. The impact is more significant for products with large list price increases or for high volume lines. To avoid pharmacy owners dispensing these products at a loss, Community Pharmacy England requested DHSC to redetermine the reimbursement prices for the products listed above.
Community Pharmacy England is awaiting confirmation of when pharmacy owners will be reimbursed at the increased list prices and will provide further updates as soon as more information becomes available.
Community Pharmacy England sought price adjustments to several other products affected by NHS list price increases in May, June and July 2026. However, DHSC took the decision not to grant price redeterminations for all the products requested. Community Pharmacy England continues to seek a review of the current price change timetable for branded products so that there is no extra months’ delay in applying any new list prices changes to reimbursement.
